Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity, and Aetna's 6947-C policy covers that use on its own criteria: "an apnea-hypopnea index (AHI) of at least 15 events per hour on polysomnography or home sleep apnea test" plus a current BMI of 30 or higher
These documents serve as proof that your expenses are approved medical costs if your administrator or the IRS ever requests verification
Wound healing accelerates dramatically
When combined with alcohol, this mechanism creates important safety considerations that patients should understand before drinking during treatment
Do not exceed 400 mg without consulting your healthcare provider
Secondary outcomes were use of semaglutide, proportion of participants achieving 5%, 10%, 15%, or 20% weight loss, and percentage change in body weight according to baseline BMI and semaglutide dosing